Results 121 to 130 of about 644,370 (183)

Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients. [PDF]

Metabolites
Jing F, Jiang L, Cao Y, Tian M, Qiu J, Zhang J, Tang L, Lu R, Hu Y.   +8 more
europepmc   +1 more source

Lesson from a metastatic male breast cancer case: CDK4/6 plus aromatase inhibitors could not exceed tamoxifen. [PDF]

Discov Oncol
Najdi T, Seif S, Damaj N, Kattan J.
europepmc   +1 more source

Dementia and Alzheimer's Disease Associated With Aromatase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase). [PDF]

Pharmacol Res Perspect
Yuste MT, Sainz-Gil M, Escudero E, Marín P.   +3 more
europepmc   +1 more source

Bone mineral density in patients using aromatase inhibitors: a clinical, nutritional, and quality of life assessment. [PDF]

Braz Oral Res
Souza AF, Barra SG, Rocha AL, Bemquerer LM, Oliveira SR, Carvalho LN, Amaral TMP, Brasileiro CB, Costa FO, Souza LN, Camargos BM, Lima EM, Ferreira AVM, Heredia JE, Oliveira MC, Macari S, Abreu LG, Mesquita RA, Silva TA.   +18 more
europepmc   +1 more source

Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study. [PDF]

Breast Cancer Res
Liu PH, Tsai CF, Hsu YC, Wu CY, Yang HY.
europepmc   +1 more source

Correction to: "The Combination of Aromatase Inhibitors and GH Treatment for Idiopathic Short Stature in Male Adolescents".

J Clin Endocrinol Metab
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Aromatase inhibitors and the endometrium

Maturitas, 2008
To investigate the potential impact of aromatase inhibitors, given after stopping tamoxifen treatment, on the endometrium of postmenopausal breast cancer patients.Review of all available literature of studies on aromatase inhibitor therapy in postmenopausal breast cancer patients previously treated with tamoxifen.(1) Endometrial thickness was found to ...
Ilan Cohen
exaly   +3 more sources